Market Report, "Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013", Published
Global Markets Direct's, 'Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Leber Congenital Amaurosis (LCA), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Leber Congenital Amaurosis (LCA). Leber Congenital Amaurosis (LCA) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release